Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Medline Inc. (MDLN : NSDQ)
 
 • Company Description   
Medline Inc. is a provider of medical surgical products and supply chain solutions serving all points of care. Medline Inc. is headquartered in Northfield, Illinois.

Number of Employees: 43,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $43.12 Daily Weekly Monthly
20 Day Moving Average: 6,936,326 shares
Shares Outstanding: 1,313.69 (millions)
Market Capitalization: $56,646.46 (millions)
Beta:
52 Week High: $50.88
52 Week Low: $34.89
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.56% 3.06%
12 Week 0.63% 5.91%
Year To Date 2.67% 6.21%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3 LAKES DRIVE
-
NORTHFIELD,IL 60093
USA
ph: 847-949-3000
fax: -
None http://www.medline.com
 
 • General Corporate Information   
Officers
James M. Boyle - Chief Executive Officer
Charles N. Mills - Chairman
James M. Pigott - President
Stephen L. Miller - Chief Operating Officer
Michael B. Drazin - Chief Financial Officer

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 58507V107
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/27/26
Share - Related Items
Shares Outstanding: 1,313.69
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $56,646.46 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.30 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.42 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 11.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 4.64% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/27/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 30.28
Trailing 12 Months: -
PEG Ratio: 6.53
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/26 - -
12/31/25 - -
09/30/25 - -
ROA
03/31/26 - -
12/31/25 - -
09/30/25 - -
Current Ratio
03/31/26 - -
12/31/25 - -
09/30/25 - -
Quick Ratio
03/31/26 - -
12/31/25 - -
09/30/25 - -
Operating Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Net Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Pre-Tax Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Book Value
03/31/26 - -
12/31/25 - -
09/30/25 - -
Inventory Turnover
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Equity
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Capital
03/31/26 - -
12/31/25 - -
09/30/25 - -
 

Powered by Zacks Investment Research ©